Form 8-K - Current report:
SEC Accession No. 0001193125-14-406136
Filing Date
2014-11-10
Accepted
2014-11-10 16:31:53
Documents
3
Period of Report
2014-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d818570d8k.htm 8-K 13884
2 EX-99.1 d818570dex991.htm EX-99.1 38100
3 GRAPHIC g818570g88s36.jpg GRAPHIC 5947
  Complete submission text file 0001193125-14-406136.txt   61452
Mailing Address 1 Broadway 14TH FLOOR Cambridge MA 02142
Business Address 1 Broadway 14TH FLOOR Cambridge MA 02142 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 141209103
SIC: 2834 Pharmaceutical Preparations